Terms: = Lung cancer AND ACSL3, PRO2194, 2181, ENSG00000123983, O95573, FACL3, ACS3 AND Treatment
6 results:
1. Risk Factors of Demoralization Among lung cancer Patients in Mainland China.
Kang T; Liu F; Jiang Q; Han J; Guo R
Am J Health Behav; 2023 Jun; 47(3):588-594. PubMed ID: 37596747
[No Abstract] [Full Text] [Related]
2. ACSL family: The regulatory mechanisms and therapeutic implications in cancer.
Quan J; Bode AM; Luo X
Eur J Pharmacol; 2021 Oct; 909():174397. PubMed ID: 34332918
[TBL] [Abstract] [Full Text] [Related]
3. Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for cancer of Unknown Primary Site: A Nonrandomized Phase 2 Clinical Trial.
Hayashi H; Takiguchi Y; Minami H; Akiyoshi K; Segawa Y; Ueda H; Iwamoto Y; Kondoh C; Matsumoto K; Takahashi S; Yasui H; Sawa T; Onozawa Y; Chiba Y; Togashi Y; Fujita Y; Sakai K; Tomida S; Nishio K; Nakagawa K
JAMA Oncol; 2020 Dec; 6(12):1931-1938. PubMed ID: 33057591
[TBL] [Abstract] [Full Text] [Related]
4. Metabolic enzyme acsl3 is a prognostic biomarker and correlates with anticancer effectiveness of statins in non-small cell lung cancer.
Fernández LP; Merino M; Colmenarejo G; Moreno-Rubio J; Sánchez-Martínez R; Quijada-Freire A; Gómez de Cedrón M; Reglero G; Casado E; Sereno M; Ramírez de Molina A
Mol Oncol; 2020 Dec; 14(12):3135-3152. PubMed ID: 33030783
[TBL] [Abstract] [Full Text] [Related]
5. Regulatory mechanism of fatty acid‑CoA metabolic enzymes under endoplasmic reticulum stress in lung cancer.
Liu KT; Yeh IJ; Chou SK; Yen MC; Kuo PL
Oncol Rep; 2018 Nov; 40(5):2674-2682. PubMed ID: 30132556
[TBL] [Abstract] [Full Text] [Related]
6. cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).
Petoumenos K; van Leuwen MT; Vajdic CM; Woolley I; Chuah J; Templeton DJ; Grulich AE; Law MG;
HIV Med; 2013 Feb; 14(2):77-84. PubMed ID: 22934689
[TBL] [Abstract] [Full Text] [Related]
